Impact of Hyperoxia and Involvement of the Immune System in Diving Accident

Last updated: April 27, 2023
Sponsor: Direction Centrale du Service de Santé des Armées
Overall Status: Active - Recruiting

Phase

N/A

Condition

N/A

Treatment

N/A

Clinical Study ID

NCT04791488
2019PBMD05
  • Ages > 18
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

The impact of oxygen therapy in many pathologies has been subject of recent work, arguing both favourable and harmful effects. Consequently, one can wonder about the influence of hyperoxic gas mixture during diving on the genesis of decompression sickness, but also about the systematic application of normobaric and hyperbaric oxygen in case of proven decompression sickness.

In mammals, normoxic concentrations have been redefined at 20-100 mbars at the extracellular level and below 10 mbars in the mitochondria.

Under hyperbaric conditions, most of the oxygen being dissolved in blood plasma, a state of hyperoxia is established which escapes the usual delivery and regulation system represented by red blood cells.

The results of our team's previous work suggest a specific effect of diving on the levels of circulating mitochondrial DNA (mtDNA), suggesting cellular destruction linked to hyperoxia/hyperbaria. In fact, our studies, carried out on both animals and human divers, have shown that diving accident leads to an increase in mtDNA levels and an immune reaction through the mobilisation of leukocytes.

The main objective of this study is to compare the influence of oxygen partial pressure levels on the evolution of clinical and biological variables during hyperbaric oxygen therapy sessions in healthy versus injured divers.

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Healthy subject with no contraindications to diving OR patient admitted to thehospital for suspicion of a diving accident OR patient admitted to the hospital forhyperbaric oxygen therapy

Exclusion

Exclusion Criteria:

  • Contraindication to diving or contraindication to hyperbaric oxygen therapy

Study Design

Total Participants: 265
Study Start date:
March 30, 2022
Estimated Completion Date:
March 30, 2028

Connect with a study center

  • Hôpital d'Instruction des Armées Sainte-Anne

    Toulon, 83800
    France

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.